Manufacturing & Packaging

Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities

Deal allows CDMO to quickly expand its drug delivery technologies in the US

Will produce plasmid DNA-based therapies, mRNA vaccine materials

CDMO looks to strengthen its presence in Belgium, Sweden and the Netherlands

Biopharma company plans for facility to also serve as its new HQ

As customer base grows, packaging company decides to wrap global divisions under one name

Latest deal expands CDMO’s biologics expertise

New large-scale plant in Barcelona part of company's capacity-expansion pursuits to capitalize on biopharma's increased demand for lyophilization equipment

Outlining the business-vital areas pharma organizations should consider today in energy risk management, including the value of resiliency

Mission is to expand its collection of mRNA vaccines beyond the Covid-19 pandemic

Mourenx location will install new equipment, add hires in project as part of the France Relance recovery plan

Facility will focus on rAAV clinical, commercial gene therapy products

Join forces on tamper-evident security for luer-lock syringes

Acquisition to expand presence in genomic medicine

Aims to enhance company's mRNA and viral vector capabilities

Horizon Therapeutics to purchase production facility from Irish specialty care company

A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories

Newly licensed US facility to increase availability of company's influenza vaccine

Health insurer Anthem joins BCBS organizations to form CivicaScript

Commercial-stage company will work with cell therapy partners to advance late-stage clinical programs

Will help UK consortium advance oral solid dosage medicines production

Site expected to begin operations by January 2022

Company's PA campus will be growing to 300,000 square feet

CDMO's Germany facility will supply starting material as part of manufacturing deal

New facilities will allow Spain CDMO to ramp up its production capacity for cell and gene therapy sector

Expansion will total over 50,000 square feet at company's existing Spokane site

CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses

Production of the key component of gene therapies and certain vaccines for Covid-19 hampered by insufficient manufacturing capacity, according to GlobalData

Vaccine maker will use CDMO’s South Korean facilities to support additional Covid doses

Expansion features a new lyophilization center to meet point-of-care demand